End-stage ADPKD with a low-frequency PKD1 mosaic variant accelerated by chemoradiotherapy
Abstract Autosomal dominant polycystic kidney disease (ADPKD) is commonly caused by PKD1, and mosaic PKD1 variants result in milder phenotypes. We present the case of a 32 year-old male with chronic active Epstein–Barr virus who underwent bone marrow transplantation with chemoradiotherapy at age 9....
Saved in:
| Main Authors: | Hiroaki Hanafusa, Hiroshi Yamaguchi, Naoya Morisada, Ming Juan YE, Riki Matsumoto, Hiroaki Nagase, Kandai Nozu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2024-03-01
|
| Series: | Human Genome Variation |
| Online Access: | https://doi.org/10.1038/s41439-024-00273-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Validating the SONG-PKD Pain Instrument, a Core Outcome Measure for Pain in ADPKD
by: Rosanna Cazzolli, et al.
Published: (2025-02-01) -
Genetic analysis and counseling of ADPKD caused by novel heterozygous mutations of PKD1 in two Chinese families: Case report
by: Yanan Wang, et al.
Published: (2024-11-01) -
G-quadruplex stabilization provokes DNA breaks in human PKD1, revealing a second hit mechanism for ADPKD
by: Agata M. Parsons, et al.
Published: (2025-01-01) -
Hypertension increases PPV for polycystic kidney disease in PKD1 and PKD2 variant carriers
by: Natalie Telis, et al.
Published: (2025-07-01) -
Total Intramuscular Fat Fraction of Thigh Muscles as a Predictor of Nusinersen Efficacy in Pediatric SMA Type II and III
by: Kiiko Iketani, et al.
Published: (2025-03-01)